| Company Name | Ambey Laboratories Limited |
| Open Date | 04-07-2024 |
| Close Date | 08-07-2024 |
| Exchange | NSE SME |
| Lot Size | 2000 Shares |
| Issue Price | ₹65 to ₹68 per share |
| Issue Size | 65,70,000 shares |
| Application Amount | ₹ 1,36,000 |
| Recommendation | Avoid |
| KPI’s | FY 22 | 2023 | Jan-24 |
| Revenue | 8,460.07 | 10,482.12 | 10,031.76 |
| EBITDA | 773.21 | 769.45 | 1,067.43 |
| Net Profit | 357.47 | 456.93 | 602.73 |
| RoCE | 13.86% | 12.67% | 15.92% |
| ROE | 18.75% | 19.33% | 17.57% |
| P/E | 9.60 | 26.46 | 20.42 |
| Opening Date | 04-07-2024 |
| Closing Date | 08-07-2024 |
| Basis of Allotment | 09-07-2024 |
| Initiation of Refunds | 10-07-2024 |
| Credit of Shares to Demat | 10-07-2024 |
| Listing Date | 11-07-2024 |
| To meet Working Capital Requirements. |
| General Corporate Expenses. |
| Issue related expenses. |
| Registered Office | Ambey Laboratories Limited Ground Floor, Property No.555 Tarla Mohalla, Ghitorni, West Delhi New Delhi, -110030 |
| Phone | 0124-4000788 |
| cs@ambeylab.com | |
| Website | http://www.ambeylab.com/ |
| Ambey Laboratories IPO DRHP |
| Ambey Laboratories IPO RHP |
| Name | Link Intime India Private Ltd |
| Phone | +91-22-4918 6270 |
| ambeylab.ipo@Linkintime.co.in | |
| Website | https://linkintime.co.in/initial_offer/public-issues.html |
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
| Share Holding Pre Issue (Promoters) | 94.97% |
| Share Holding Post Issue (Promoters) | 69.90% |